Walkey Allan J, Lagu Tara, Lindenauer Peter K
1 The Pulmonary Center, Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Boston University School of Medicine, Boston, Massachusetts.
Ann Am Thorac Soc. 2015 Feb;12(2):216-20. doi: 10.1513/AnnalsATS.201411-498BC.
Stakeholders seek to monitor processes and outcomes of care among patients with sepsis, but use of administrative data for sepsis surveillance is controversial. Prior studies using only principal diagnoses from claims data have shown a trend of rising sepsis incidence with falling infection incidence, implying that administrative data are inaccurate for sepsis surveillance.
Because a sepsis diagnosis often modifies an infection site diagnosis, we sought to investigate trends in sepsis and infection using both principal and secondary diagnoses in administrative data.
This was a retrospective cohort study. We used data from the Nationwide Inpatient Sample years 2003 to 2009 to identify age-standardized, population-based trends in sepsis and infection using all available diagnosis codes. Infection sites were defined as bacteremia, pneumonia, urinary tract, skin/soft tissue, and gastrointestinal; codes for septicemia, sepsis, severe sepsis, and septic shock were used to identify "sepsis." We identified patients with infection and mechanical ventilation to estimate incidence of severe sepsis without requiring specific claims for sepsis or acute organ failure.
We identified 53.9 million adult infection hospitalizations during the years 2003 to 2009; average age was 63 years, 61% of patients were women, and 70% reported white race, 14% black, and 11% Hispanic ethnicity. Incidence of hospitalizations with an infection claim increased from 3,147/100,000 U.S. residents in 2003 to 3,480/100,000 in 2009 (11% increase), whereas hospitalizations with sepsis claims increased from 359/100,000 to 535/100,000 residents during the same time frame (49% increase); P = 0.009 between infection and sepsis trends. The proportion of infection hospitalizations with a sepsis claim increased from 7.5% in 2003 to 11.5% in 2009 (54% increase). The incidence of hospitalizations with both an infection and mechanical ventilation claim during 2003 was 173/100,000 as compared with 251/100,000 in 2009 (45% increase); P = 0.76 compared with sepsis trends.
Sepsis claims are increasing at a greater rate than infection claims but are not inversely related. Trends in sepsis are similar to trends in infection cases requiring mechanical ventilation. Further studies should seek to identify the optimal algorithms to identify sepsis within administrative data and explore potential mechanisms for the increasing incidence of infection and sepsis in the United States.
利益相关者试图监测脓毒症患者的治疗过程和结果,但使用行政数据进行脓毒症监测存在争议。以往仅使用索赔数据中的主要诊断进行的研究显示,随着感染发病率下降,脓毒症发病率呈上升趋势,这意味着行政数据用于脓毒症监测并不准确。
由于脓毒症诊断常常会改变感染部位诊断,我们试图利用行政数据中的主要和次要诊断来研究脓毒症和感染的趋势。
这是一项回顾性队列研究。我们使用2003年至2009年全国住院患者样本数据,通过所有可用的诊断代码来确定脓毒症和感染的年龄标准化、基于人群的趋势。感染部位定义为菌血症、肺炎、泌尿系统、皮肤/软组织和胃肠道;使用败血症、脓毒症、严重脓毒症和感染性休克的代码来识别“脓毒症”。我们确定了感染和机械通气患者,以估计严重脓毒症的发病率,而无需特定的脓毒症或急性器官衰竭索赔。
我们在2003年至2009年期间确定了5390万例成人感染住院病例;平均年龄为63岁,61%的患者为女性,70%报告为白人,14%为黑人,11%为西班牙裔。有感染索赔的住院发病率从2003年的每10万美国居民3147例增加到2009年的3480例(增加11%),而同期有脓毒症索赔的住院病例从每10万居民359例增加到535例(增加49%);感染和脓毒症趋势之间的P值为0.009。有脓毒症索赔的感染住院病例比例从2003年的7.5%增加到2009年的11.5%(增加54%)。2003年有感染和机械通气索赔的住院发病率为每10万居民173例,而2009年为251例(增加45%);与脓毒症趋势相比,P值为0.76。
脓毒症索赔的增长速度高于感染索赔,但并非呈负相关。脓毒症趋势与需要机械通气的感染病例趋势相似。进一步的研究应寻求确定在行政数据中识别脓毒症的最佳算法,并探索美国感染和脓毒症发病率增加的潜在机制。